EcoDrugPlus

Ensembl ID : ENSOMYG00000042397
Gene Symbol: -
Cross references: -
152 Possible Orthologues:

Ensembl ID : ENSOMYG00000043019
Gene Symbol: -
Cross references: -
245 Possible Orthologues:

Ensembl ID : ENSOMYG00000041292
Gene Symbol: -
Cross references: -
222 Possible Orthologues:

Ensembl ID : ENSOMYG00000043119
Gene Symbol: -
Cross references: -
201 Possible Orthologues:

Ensembl ID : ENSOMYG00000043161
Gene Symbol: -
Cross references: -
408 Possible Orthologues:

Ensembl ID : ENSOMYG00000043308
Gene Symbol: -
Cross references: -
154 Possible Orthologues:

Ensembl ID : ENSOMYG00000041192
Gene Symbol: -
Cross references: -
200 Possible Orthologues:

Ensembl ID : ENSOMYG00000043879
Gene Symbol: RPSA
1 Cross references
499 Possible Orthologues:

Ensembl ID : ENSOMYG00000043955
Gene Symbol: -
Cross references: -
345 Possible Orthologues:

Ensembl ID : ENSOMYG00000040995
Gene Symbol: -
Cross references: -
172 Possible Orthologues:

Ensembl ID : ENSOMYG00000039617
Gene Symbol: -
Cross references: -
183 Possible Orthologues:

Ensembl ID : ENSOMYG00000039533
Gene Symbol: -
Cross references: -
382 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).